Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study (2022)
Attributed to:
Developing a decision support tool to enable precision treatment of type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 4
Parent Publication: LANCET DIGITAL HEALTH
Issue: 12